These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24009132)

  • 1. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
    Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
    Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
    Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
    Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
    Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
    Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia.
    Silveira A; Carlo A; Adam M; McLeod O; Lundman P; Boquist S; Woodhams BJ; Hamsten A
    Int J Lab Hematol; 2018 Jun; 40(3):251-257. PubMed ID: 29356352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
    Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
    Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
    Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
    Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.
    Owen BA; Xue A; Heit JA; Owen WG
    Thromb Res; 2011 Jan; 127(1):39-46. PubMed ID: 21106230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
    Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
    Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study.
    Syrigos K; Grapsa D; Sangare R; Evmorfiadis I; Larsen AK; Van Dreden P; Boura P; Charpidou A; Kotteas E; Sergentanis TN; Elalamy I; Falanga A; Gerotziafas GT
    Oncologist; 2018 Nov; 23(11):1372-1381. PubMed ID: 30104289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the tissue factor-dependent extrinsic pathway and its relation to JAK2 V617F mutation status in patients with essential thrombocythemia.
    Gadomska G; Stankowska K; Boinska J; Bartoszewska-Kubiak A; Haus O; Rość D
    Blood Coagul Fibrinolysis; 2016 Oct; 27(7):817-821. PubMed ID: 26945263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
    Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
    Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.
    Falanga A; Marchetti M; Vignoli A; Balducci D; Russo L; Guerini V; Barbui T
    Exp Hematol; 2007 May; 35(5):702-11. PubMed ID: 17577920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
    Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
    J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
    Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
    Boknäs N; Faxälv L; Lindahl TL; Ramström S
    J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
    Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
    J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.